Taking On Big Pharma
9:12–10:08 · 57s
Kris explains how compounders filled the GLP-1 shortage, earned a rare nod from Novo Nordisk’s CEO, and why large pharmaceutical companies now view them as unwelcome competition.
9:12–10:08 · 57s
Kris explains how compounders filled the GLP-1 shortage, earned a rare nod from Novo Nordisk’s CEO, and why large pharmaceutical companies now view them as unwelcome competition.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.